KRISTEN LEHMBECK: Open Payments
NPI 1316339203 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$491 in 24 payments from 10 companies in 2025. Trend: 2023 $353 · 2024 $417 · 2025 $491
Food & beverage: $491
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 9 | $154 |
| Astellas Pharma US Inc | 3 | $66 |
| Organon LLC | 3 | $64 |
| Merck Sharp & Dohme LLC | 2 | $43 |
| ABBVIE INC. | 2 | $39 |
| CooperSurgical, Inc. | 1 | $34 |
| Davol Inc. | 1 | $29 |
| Hologic Sales and Service, LLC | 1 | $23 |
| MILLICENT US INC | 1 | $21 |
| Smith+Nephew, Inc. | 1 | $18 |
Products named: ZURZUVAE, Veozah, NEXPLANON, GARDASIL 9, Paragard T 380A, ARISTA, LO LOESTRIN FE, ACESSA PROVU SYSTEM.
Industry payments across AZ — which companies pay providers there.
